A 5-year-old boy with known idiopathic generalized epilepsy is brought to the emergency department in status epilepticus. After initial seizure control with intravenous lorazepam and phenytoin, the seizures recur. To guide further antiepileptic drug selection and assess for non-convulsive seizure activity, which investigation is most appropriate?

## Investigation of Choice for Refractory Status Epilepticus ### Clinical Scenario Analysis A child with known epilepsy presenting with refractory status epilepticus (seizures persisting despite first-line agents) requires: 1. Assessment of ongoing seizure activity (clinical vs. non-convulsive) 2. Monitoring of brain electrical activity to guide second-line therapy 3. Detection of subtle or subclinical seizures ### Why Continuous EEG Monitoring is Essential **Key Point:** Continuous EEG (cEEG) is the gold standard for detecting both convulsive and non-convulsive seizures in status epilepticus. In refractory cases, non-convulsive seizures may persist despite apparent clinical seizure control. **High-Yield:** Non-convulsive status epilepticus (NCSE) is common in children with refractory seizures and is often missed clinically. cEEG is the ONLY way to detect NCSE and guide escalation of therapy. **Clinical Pearl:** After initial seizure control, clinical observation alone is insufficient. Up to 10–15% of children in apparent "post-ictal" state are actually in non-convulsive status epilepticus. cEEG detects this and prevents neuronal injury from ongoing electrical activity. ### Role of cEEG in Refractory Status Epilepticus ```mermaid flowchart TD A[Status Epilepticus]:::outcome --> B[First-line agents:<br/>Lorazepam + Phenytoin]:::action B --> C{Seizure control?}:::decision C -->|Yes, clinically| D[cEEG monitoring]:::action C -->|No| E[Second-line agents:<br/>Levetiracetam, Lacosamide]:::action D --> F{EEG shows seizures?}:::decision F -->|Yes: NCSE| G[Escalate therapy]:::urgent F -->|No| H[Continue monitoring]:::action E --> I[cEEG to guide therapy]:::action ``` **Mnemonic: NCSE** — **N**on-convulsive **S**tatus **E**pilepticus (detected only by EEG, not clinical exam) ### Comparison of Investigations in Refractory Status Epilepticus | Investigation | Timing | Purpose | Utility in Refractory SE | |---|---|---|---| | Serum phenytoin level | After 2nd dose (30 min) | Assess drug levels | Low — does not guide next therapy choice | | cEEG monitoring | Continuous, during SE | Detect convulsive + non-convulsive seizures | **HIGH** — essential for diagnosis and management | | Diffusion-weighted MRI | After seizure control | Assess for acute ischemic injury | Late; not for acute management | | CSF analysis | If fever/infection suspected | Rule out meningitis/encephalitis | Only if clinical indicators present | **Warning:** Do not rely on clinical observation alone in refractory status epilepticus. Absence of visible seizure activity does NOT mean seizures have stopped — cEEG is mandatory. ### When cEEG is Indicated - Refractory status epilepticus (seizures despite first-line agents) - Suspected non-convulsive seizures - Altered consciousness without visible seizure activity - Monitoring response to second-line antiepileptic drugs - Detecting electrographic seizures during sedation/paralysis [cite:Nelson Textbook of Pediatrics 21e Ch 608; Pediatric Neurology: Principles and Practice 6e Ch 39]